...
Dryness & GSM faq

Tips to make intimacy more comfortable during GSM?

Tips to make intimacy more comfortable during GSM? Start with friction control: schedule a vaginal moisturiser and use the right lubricant every time (water-based for versatility, silicone-based for the longest glide, oil-based for richness but not latex-safe). Warm up slowly, pause if there’s stinging, and prioritise positions with control and shallow depth. Add local vaginal oestrogen or DHEA if acceptable, and consider pelvic health physio for muscle guarding. Educational only. Results vary. Not a cure.

Clinical Context

Who benefits most from these tips? People whose main limiter is vestibular sting and micro-tears with penetration. Precision (treat the entrance) and the right lubricant (silicone-based often provides the longest glide) can transform comfort even before other steps.

Who should seek earlier review? Anyone with red flags: malodorous green/grey discharge, severe pelvic pain, fever, visible haematuria, or new post-menopausal bleeding. Pain that feels deep rather than at the entrance can reflect pelvic floor contributors or conditions like endometriosis/adenomyosis and needs a tailored plan.

Alternatives and next steps. If hormones are unsuitable or declined, double-down on non-hormonal care: scheduled moisturiser, generous compatible lubricant, gentle cleansing, breathable fabrics, and pelvic health physiotherapy for guarding. If foundations help but don’t fully solve dyspareunia, discuss adding local oestrogen/DHEA or, selectively, device-based or injectable adjuncts after careful assessment.

Evidence-Based Approaches

Patient-friendly overview: The NHS explains symptoms, self-care and when to seek help for vaginal dryness, including the role of moisturisers and lubricants.

Guideline framing (UK): The NICE Menopause Guideline (NG23) recommends offering vaginal moisturisers and lubricants and considering low-dose local vaginal oestrogen when GSM affects quality of life; local options can be used with or without HRT.

Prescribing detail: UK product information and cautions for local therapies (vaginal oestrogens and prasterone/DHEA) are set out in the British National Formulary (BNF), which supports safe selection and vestibule-aware technique.

Effectiveness benchmarks: Systematic reviews in the Cochrane Library show local vaginal oestrogens improve dryness, soreness, dyspareunia and vaginal pH versus placebo across creams, tablets/pessaries and rings—useful context when weighing adjuncts.

Pathophysiology & nuance: Peer-reviewed overviews indexed on PubMed describe GSM biology (thinner epithelium, raised pH, reduced lactobacilli), clarifying why friction control + local therapy + pelvic floor strategies often restore comfort more reliably than devices alone.